To make further progress in understanding the unique cardiac disease characteristics of patients with HFpEF and a normal NT-proBNP level and to better tailor treatment, future studies should ...
Nivolumab Plus Chemotherapy in Epidermal Growth Factor Receptor–Mutated Metastatic Non–Small-Cell Lung Cancer After Disease Progression on Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: ...
Please provide your email address to receive an email when new articles are posted on . Cancer survivors with increased NT-proBNP levels had an elevated risk for all-cause and cardiac mortality.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback